- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00945698
Prevention of Linear Growth Failure in Infants and Young Children With Lipid-based Nutrient Supplements (iLiNS-DOSE) (iLiNS-DOSE)
May 26, 2015 updated by: Per Ashorn, Tampere University
A Two-centre, Randomised, Single-blind, Parallel Group Controlled Trial, Testing the Growth Promoting Effect of Long-term Complementary Feeding of Infants With Different Doses and Formulations of Lipid-based Nutrient Supplements (LNS)
The use of lipid-based nutrients (LNS), such as Nutributter or fortified spread (FS), have been associated with improved growth and development outcomes among infants in Ghana and Malawi.
Modified versions of such supplements have been developed to improve their nutrient density and quality and to lower their costs.
Such modified products have proven acceptable to infants and their guardians in Malawi and Ghana.
In the present trial, the investigator aim to identify the lowest growth-promoting daily dose of modified LNS.
Additionally, the investigators will test a hypothesis that LNS that does not contain milk promotes growth as well as milk-containing LNS when given for 12 months at a 10-40 g daily dose to 6-18 month old infants in rural Malawi.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
- Dietary supplement: Maize-soy flour
- Dietary supplement: Lipid-based nutrient supplement, 10gM
- Dietary supplement: Lipid-based nutrient supplement, 20gM
- Dietary supplement: Lipid-based Nutrient Supplement, 20gNoM
- Dietary supplement: Lipid-based nutrient supplement, 40gM
- Dietary supplement: Lipid-based Nutrient Supplement, 40gNoM
Detailed Description
Six-month old healthy infants are identified through community surveys in the study area.
1920 infants meeting set criteria are randomised into receiving the following intervention between 6 and 18 months of age: 1) standard treatment from 6-18 months (i.e.no supplements, with delayed intervention between 18-30 months of age (ST-DI), 2) 10 g / day milk-containing LNS (LNS-10gM), 3) 20 g / day milk-containing LNS (LNS-20gM), 4) 20 g / day milk-free LNS (LNS-20gNoM), 5) 40 g / day milk-containing LNS, (LNS-40gM) 6) 40 g / day milk-free LNS (LNS-40gNoM).
The families receive the food supplements at 2-weekly intervals and the participants undergo a morbidity evaluation weekly, a limited development assessment at 4-weekly intervals and anthropometric evaluation at 26-week intervals and laboratory analyses at enrollment and at 18 months.
Growth outcome analyses are done at 18 and at 42 months of age.
Study Type
Interventional
Enrollment (Anticipated)
1920
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Mangochi, Malawi
- University of Malawi, College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 months to 6 months (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Signed informed consent from at least one guardian
- Age 5.50 months to 6.49 months
- Availability during the period of the study.
- Permanent resident of Mangochi District Hospital or Namwera Health Centre catchment area
Exclusion Criteria:
- Weight for length Z score (WLZ) < -2.0
- Presence of oedema
- Severe anaemia (Hb<50 g / l)
- Severe illness warranting hospital referral
- History of allergy towards peanut
- History of anaphylaxis or serious allergic reaction to any substance, requiring emergency medical care
- Concurrent participation in any other clinical trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: ST-DI (Delayed intervention)
|
|
Experimental: LNS-10gM
|
|
Experimental: LNS-20gM
|
|
Experimental: LNS-20gNoM
|
|
Experimental: LNS-40gM
|
|
Experimental: LNS-40gNoM
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in length-for-age Z-score (LAZ, based on WHO 2005 MGRS) between enrollment and 18 months of age
Time Frame: Primarily 12 months after enrollment (age 18 months), secondarily 36 months after enrollment (age 42 months)
|
Primarily 12 months after enrollment (age 18 months), secondarily 36 months after enrollment (age 42 months)
|
Incidence of serious adverse events during the study period
Time Frame: 12 months after enrollment (age 18 months)
|
12 months after enrollment (age 18 months)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in weight-for-age (WAZ) and weight-for-length (WLZ) Z-scores
Time Frame: Primarily 12 months after enrollment (age 18 months), secondarily 36 months after enrollment (age 42 months)
|
Primarily 12 months after enrollment (age 18 months), secondarily 36 months after enrollment (age 42 months)
|
Incidence of stunting, underweight, and wasting
Time Frame: Primarily 12 months after enrollment (age 18 months), secondarily 36 months after enrollment (age 42 months)
|
Primarily 12 months after enrollment (age 18 months), secondarily 36 months after enrollment (age 42 months)
|
Prevalence of reduced appetite
Time Frame: Daily assessment during 12 month supplementation
|
Daily assessment during 12 month supplementation
|
Energy intake from complementary foods
Time Frame: 3 and 9 months after enrollment (age 9 and 15 months)
|
3 and 9 months after enrollment (age 9 and 15 months)
|
Incidence of laboratory-confirmed malaria infection
Time Frame: 12 months after enrollment (age 18 months)
|
12 months after enrollment (age 18 months)
|
Incidence of caregiver-reported morbidity
Time Frame: Daily assessment during 12 month supplementation
|
Daily assessment during 12 month supplementation
|
Immune function (measured by humoral immunity towards measles vaccination)
Time Frame: 12 months after enrollment (age 18 months)
|
12 months after enrollment (age 18 months)
|
Change in hemoglobin and micronutrient status (iron status, measured by zinc protoporphyrin (ZPP); plasma zinc; plasma vitamin A; B-vitamins and related metabolites; urine iodine
Time Frame: 12 months after enrollment (age 18 months)
|
12 months after enrollment (age 18 months)
|
Proportion with anaemia at 18 months of age
Time Frame: 12 months after enrollment (age 18 months)
|
12 months after enrollment (age 18 months)
|
Change in erythrocyte essential fatty acid (EFA) concentration (measured from a subsample of 400 participants)
Time Frame: 12 months after enrollment (age 18 months)
|
12 months after enrollment (age 18 months)
|
Neuro-behavioral development (timing of acquisition of the certain skills and more comprehensive analysis at the age of 18 months)
Time Frame: Limited assessment every 4 weeks during the 12 months supplementation, more comprehensive at age 18 months
|
Limited assessment every 4 weeks during the 12 months supplementation, more comprehensive at age 18 months
|
Incidence of all adverse events during the study period
Time Frame: 12 months after enrollment (age 18 months)
|
12 months after enrollment (age 18 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kenneth Maleta, MBBS, PhD, Kamuzu University of Health Sciences
- Principal Investigator: Per Ashorn, MD, PhD, University of Tampere Medical School
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Adu-Afarwuah S, Lartey A, Brown KH, Zlotkin S, Briend A, Dewey KG. Home fortification of complementary foods with micronutrient supplements is well accepted and has positive effects on infant iron status in Ghana. Am J Clin Nutr. 2008 Apr;87(4):929-38. doi: 10.1093/ajcn/87.4.929.
- Bendabenda J, Patson N, Hallamaa L, Ashorn U, Dewey KG, Ashorn P, Maleta K. Does anthropometric status at 6 months predict the over-dispersion of malaria infections in children aged 6-18 months? A prospective cohort study. Malar J. 2019 Apr 22;18(1):143. doi: 10.1186/s12936-019-2778-y.
- Bendabenda J, Patson N, Hallamaa L, Mbotwa J, Mangani C, Phuka J, Prado EL, Cheung YB, Ashorn U, Dewey KG, Ashorn P, Maleta K. The association of malaria morbidity with linear growth, hemoglobin, iron status, and development in young Malawian children: a prospective cohort study. BMC Pediatr. 2018 Dec 28;18(1):396. doi: 10.1186/s12887-018-1378-2.
- Adams KP, Ayifah E, Phiri TE, Mridha MK, Adu-Afarwuah S, Arimond M, Arnold CD, Cummins J, Hussain S, Kumwenda C, Matias SL, Ashorn U, Lartey A, Maleta KM, Vosti SA, Dewey KG. Maternal and Child Supplementation with Lipid-Based Nutrient Supplements, but Not Child Supplementation Alone, Decreases Self-Reported Household Food Insecurity in Some Settings. J Nutr. 2017 Dec;147(12):2309-2318. doi: 10.3945/jn.117.257386. Epub 2017 Oct 4.
- Prado EL, Abbeddou S, Adu-Afarwuah S, Arimond M, Ashorn P, Ashorn U, Brown KH, Hess SY, Lartey A, Maleta K, Ocansey E, Ouedraogo JB, Phuka J, Some JW, Vosti SA, Yakes Jimenez E, Dewey KG. Linear Growth and Child Development in Burkina Faso, Ghana, and Malawi. Pediatrics. 2016 Aug;138(2):e20154698. doi: 10.1542/peds.2015-4698.
- Phuka JC, Maleta K, Thakwalakwa C, Cheung YB, Briend A, Manary MJ, Ashorn P. Complementary feeding with fortified spread and incidence of severe stunting in 6- to 18-month-old rural Malawians. Arch Pediatr Adolesc Med. 2008 Jul;162(7):619-26. doi: 10.1001/archpedi.162.7.619. Erratum In: Arch Pediatr Adolesc Med. 2008 Oct;162(10):942.
- Phuka JC, Maleta K, Thakwalakwa C, Cheung YB, Briend A, Manary MJ, Ashorn P. Postintervention growth of Malawian children who received 12-mo dietary complementation with a lipid-based nutrient supplement or maize-soy flour. Am J Clin Nutr. 2009 Jan;89(1):382-90. doi: 10.3945/ajcn.2008.26483. Epub 2008 Dec 3.
- Kumwenda C, Hemsworth J, Phuka J, Ashorn U, Arimond M, Maleta K, Prado EL, Haskell MJ, Dewey KG, Ashorn P. Association between breast milk intake at 9-10 months of age and growth and development among Malawian young children. Matern Child Nutr. 2018 Jul;14(3):e12582. doi: 10.1111/mcn.12582. Epub 2018 Jan 19.
- Bendabenda J, Alho L, Ashorn U, Cheung YB, Dewey KG, Vosti SA, Phuka J, Maleta K, Ashorn P. The effect of providing lipid-based nutrient supplements on morbidity in rural Malawian infants and young children: a randomized controlled trial. Public Health Nutr. 2016 Jul;19(10):1893-903. doi: 10.1017/S1368980016000331. Epub 2016 Mar 9.
- Hemsworth J, Kumwenda C, Arimond M, Maleta K, Phuka J, Rehman AM, Vosti SA, Ashorn U, Filteau S, Dewey KG, Ashorn P, Ferguson EL. Lipid-Based Nutrient Supplements Increase Energy and Macronutrient Intakes from Complementary Food among Malawian Infants. J Nutr. 2016 Feb;146(2):326-34. doi: 10.3945/jn.115.215327. Epub 2016 Jan 6.
- Maleta KM, Phuka J, Alho L, Cheung YB, Dewey KG, Ashorn U, Phiri N, Phiri TE, Vosti SA, Zeilani M, Kumwenda C, Bendabenda J, Pulakka A, Ashorn P. Provision of 10-40 g/d Lipid-Based Nutrient Supplements from 6 to 18 Months of Age Does Not Prevent Linear Growth Faltering in Malawi. J Nutr. 2015 Aug;145(8):1909-15. doi: 10.3945/jn.114.208181. Epub 2015 Jun 10.
- Ashorn U, Alho L, Arimond M, Dewey KG, Maleta K, Phiri N, Phuka J, Vosti SA, Zeilani M, Ashorn P. Malawian Mothers Consider Lipid-Based Nutrient Supplements Acceptable for Children throughout a 1-Year Intervention, but Deviation from User Recommendations Is Common. J Nutr. 2015 Jul;145(7):1588-95. doi: 10.3945/jn.114.209593. Epub 2015 May 20.
- Kumwenda C, Dewey KG, Hemsworth J, Ashorn P, Maleta K, Haskell MJ. Lipid-based nutrient supplements do not decrease breast milk intake of Malawian infants. Am J Clin Nutr. 2014 Mar;99(3):617-23. doi: 10.3945/ajcn.113.076588. Epub 2013 Dec 24.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2009
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
August 1, 2014
Study Registration Dates
First Submitted
July 21, 2009
First Submitted That Met QC Criteria
July 21, 2009
First Posted (Estimate)
July 24, 2009
Study Record Updates
Last Update Posted (Estimate)
May 27, 2015
Last Update Submitted That Met QC Criteria
May 26, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- iLiNS-DOSE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malnutrition
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
International Centre for Diarrhoeal Disease Research...GlaxoSmithKline; Stanford UniversityCompletedMalnutrition | Malnutrition in Children | Child MalnutritionBangladesh
-
University of Nove de JulhoUnknownMalnutrition, ChildBrazil
-
International Centre for Diarrhoeal Disease Research...UNICEFNot yet recruitingMalnutrition SevereBangladesh
-
Aga Khan UniversityAction Contre la FaimCompletedEvaluation of the Effectiveness and Impact of Community Case Management of Severe Acute MalnutritionSevere MalnutritionPakistan
-
University of Erlangen-Nürnberg Medical SchoolPfrimmer Nutricia GmbH, Erlangen , GermanyCompletedNursing Home Residents | Malnutrition or Risk of MalnutritionGermany
-
UNICEFSave the ChildrenCompletedSevere MalnutritionCongo, The Democratic Republic of the
-
Rennes University HospitalRecruiting
-
Society for Applied StudiesWorld Health Organization; Christian Medical College, Vellore, India; ArthCompletedUncomplicated Severe Acute MalnutritionIndia
-
Alliance for International Medical ActionBien Être de La femme et de L'Enfant au NigerCompletedMalnutrition | Kwashiorkor | Marasmus | Malnutrition; Degree, ModerateNiger
Clinical Trials on Maize-soy flour
-
Tampere UniversityAcademy of Finland; Foundation for Paediatric Research, FinlandCompleted
-
Tampere UniversityCompleted
-
Tampere UniversityKamuzu University of Health Sciences; Academy of Finland; Foundation for Paediatric... and other collaboratorsCompletedMalnutrition | Developmental Delay | StuntingMalawi
-
University of FloridaMichigan State UniversityCompleted
-
Tampere UniversityAcademy of Finland; Foundation for Paediatric Research, FinlandCompleted
-
Tampere UniversityKamuzu University of Health SciencesCompleted
-
University of ManitobaManitoba Pulse GrowersCompleted
-
Johns Hopkins Bloomberg School of Public HealthTropical Diseases Research Centre, Zambia; HarvestPlus; Canadian International... and other collaboratorsCompletedVitamin A Deficiency | Low Serum RetinolZambia
-
Chinese University of Hong KongUnknown
-
University of Colorado, DenverUniversity Teaching Hospital, Lusaka, Zambia; HarvestPlusCompletedNutritional DeficiencyUnited States, Zambia